Cresilon closes $25 million Series A-4 financing

Cresilon, Inc. completed a $25 million Series A-4 financing round to accelerate global expansion, increase production capacity at its Brooklyn biomanufacturing facility, and support entry into the human health market.

“The financing will support the company’s efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.”cresilon.com

• 1 source
• cresilon.comCresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market - CresiloncresilonOct 27, 2022

Summarized from public sources; check the original articles before acting on it.